FollowTheFilings

Managers Activity Compare Newest

Investment

BRIDGEBIO PHARMA INC

Historical 13F holders

CUSIP: 10806XAJ1
Type: Debt
Class: NOTE 1.750% 3/0

Period	13F filings
2026 Q1	2

FollowTheFilings · Institutional 13F data room

All managers Activity Compare Newest filings X

Data is sourced from SEC EDGAR as filed. The SEC does not guarantee accuracy or completeness. Holdings exclude shorts and many derivatives; values are as of the report date.